{"id":3943,"date":"2024-02-14T10:39:12","date_gmt":"2024-02-14T10:39:12","guid":{"rendered":"https:\/\/staging.aliathbio.com\/?p=3943"},"modified":"2024-02-14T10:39:58","modified_gmt":"2024-02-14T10:39:58","slug":"binx-health-cardinal-health-2","status":"publish","type":"post","link":"https:\/\/staging.aliathbio.com\/?p=3943","title":{"rendered":"Peptomyc\u2019s first MYC inhibitor, OMO-103, demonstrates safety and anti-tumor activity in a phase I clinical trial"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3943\" class=\"elementor elementor-3943\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ea3dfd elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ea3dfd\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5adfc7f6\" data-id=\"5adfc7f6\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-53e8f764 elementor-widget elementor-widget-text-editor\" data-id=\"53e8f764\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><\/p>\n<p>Peptomyc is proud to announce that the results of the MYCure clinical trial have just been published in Nature Medicine (<a href=\"https:\/\/www.nature.com\/articles\/s41591-024-02805-1\" target=\"_blank\" rel=\"noopener\">https:\/\/www.nature.com\/articles\/s41591-024-02805-1<\/a>), demonstrating the unique potential of our lead first-in-class MYC inhibitor, OMO-103, to treat multiple oncological indications. Peptomyc takes pride in pioneering the blockade of a most-wanted target in cancer, and we believe this encouraging data, along with our preclinical findings, underscore the importance of MYC inhibition in the treatment of cancer.<\/p>\n<p>\u00a0<\/p>\n<p><\/p>\n<p><\/p>\n<p class=\"has-medium-font-size\"><a href=\"https:\/\/www.peptomyc.com\/published-today-in-nature-medicine-peptomycs-first-myc-inhibitor-omo-103-demonstrates-safety-and-anti-tumor-activity-in-a-phase-i-clinical-trial\/\" target=\"_blank\" rel=\"noopener\">Read more<\/a><\/p>\n<p><\/p>\n<p><\/p>\n<div class=\"wp-block-spacer\" style=\"height: 50px;\" aria-hidden=\"true\">\u00a0<\/div>\n<p><\/p>\n<p><\/p>\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n<p><\/p>\n<p><\/p>\n<div class=\"wp-block-spacer\" style=\"height: 100px;\" aria-hidden=\"true\">\u00a0<\/div>\n<p><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Peptomyc is proud to announce that the results of the MYCure clinical trial have just been published in Nature Medicine (https:\/\/www.nature.com\/articles\/s41591-024-02805-1), demonstrating the unique potential of our lead first-in-class MYC inhibitor, OMO-103, to treat multiple oncological indications. Peptomyc takes pride in pioneering the blockade of a most-wanted target in cancer, and we believe this encouraging [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3949,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-3943","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-portfolio"],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/posts\/3943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3943"}],"version-history":[{"count":0,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/posts\/3943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=\/wp\/v2\/media\/3949"}],"wp:attachment":[{"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.aliathbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}